Electroporation and use of hepatitis B virus envelope L proteins as bionanocapsules

Cold Spring Harbor Protocols

Volumn 7, Issue 6, 2012, Pages 702-705

  Yamada, Tadanori ^a   Jung, Joohee ^a   Seno, Masaharu ^a   Kondo, Akihiko ^a   Ueda, Masakazu ^a   Tanizawa, Katsuyuki ^a   Kuroda, Shun'ichi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIONANOCAPSULE; NANOCAPSULE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; DRUG CARRIER; L PROTEIN, HEPATITIS B VIRUS; NANOPARTICLE; RECOMBINANT PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ELECTROPORATION; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; ANIMAL; GENETICS; LIVER; LIVER CELL; METABOLISM; METHODOLOGY; SACCHAROMYCES CEREVISIAE;

ANIMALS; DRUG CARRIERS; ELECTROPORATION; HEPATOCYTES; HUMANS; LIVER; MICE; NANOPARTICLES; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; VIRAL ENVELOPE PROTEINS;

EID: 84862151886     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.prot069534     Document Type: Article

References (5)

1. Kuroda S, Itoh Y, Miyazaki T, Otaka-Imai S, Fujisawa Y. 1989. Efficient expression of genetically engineered hepatitis B virus surface antigen P31 proteins in yeast. Gene 78: 297-308.
2. Kuroda S, Fujisawa Y, Iino S, Akahane Y, Suzuki H. 1991. Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine). Vaccine 9: 163-169.
3. Kuroda S, Otaka S, Miyazaki T, Nakao M, Fujisawa Y. 1992. Hepatitis B virus envelope L protein particles: Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J Biol Chem 267: 1953-1961.
4. Yamada T, Iwabuki H, Kanno T, Tanaka H, Kawai T, Fukuda H, Kondo A, Seno M, Tanizawa K, Kuroda S. 2001. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein. Vaccine 19: 3154-3163.
5. Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MKL, VandenDriessche T, Fukuda H, Kondo A, Ueda M, Seno M, et al. 2003. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol 21: 885-890.